The federal government has purchased 600,000 treatment courses of a new monoclonal antibody treatment that data shows works against the Omicron variant.
Omicron currently is estimated to make up about 100% of all COVID-19 cases in the United States.
HHS stands ready with 600,000 courses of new antibody treatment against Omicron
